CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-04-05 | Hora Maninder SVP Pharma Dev & Mfg Ops | Sale | −180,000 | $21.70 | $3.9M | 63,648 |
| 2017-04-05 | Hora Maninder SVP Pharma Dev & Mfg Ops | Exercise or conversion · Stock Option | −180,000 | 0 | ||
| 2017-04-05 | KUEBLER CHRISTOPHER A Director | Exercise or conversion | +15,000 | $8.37 | $126K | 50,500 |
| 2017-04-05 | KUEBLER CHRISTOPHER A Director | Sale | −15,000 | $21.88 | $328K | 35,500 |
| 2017-04-05 | KUEBLER CHRISTOPHER A Director | Exercise or conversion · Stock Option | −15,000 | 0 | ||
| 2017-03-20 | Thomsen Jillian B. SVP & Chief Accounting Officer | Exercise or conversion | +75,000 | $11.34 | $851K | 130,637 |
| 2017-03-20 | Thomsen Jillian B. SVP & Chief Accounting Officer | Exercise or conversion | +37,500 | $7.21 | $270K | 168,137 |
| 2017-03-20 | Thomsen Jillian B. SVP & Chief Accounting Officer | Sale | −112,500 | $19.69 | $2.2M | 55,637 |
| 2017-03-20 | Thomsen Jillian B. SVP & Chief Accounting Officer | Exercise or conversion · Stock Option | −75,000 | 0 | ||
| 2017-03-20 | Thomsen Jillian B. SVP & Chief Accounting Officer | Exercise or conversion · Stock Option | −37,500 | 0 | ||
| 2017-03-15 | WHITFIELD ROY A Director | Exercise or conversion | +14,000 | $8.37 | $117K | 98,000 |
| 2017-03-15 | WHITFIELD ROY A Director | Exercise or conversion · Stock Option | −14,000 | 0 | ||
| 2017-03-14 | CHESS ROBERT Director | Exercise or conversion | +5,000 | $8.37 | $42K | 276,623 |
| 2017-03-14 | CHESS ROBERT Director | Sale | −5,000 | $15.41 | $77K | 271,623 |
| 2017-03-14 | CHESS ROBERT Director | Exercise or conversion · Stock Option | −5,000 | 10,000 | ||
| 2017-03-03 | Labrucherie Gil M SVP & Chief Financial Officer | Exercise or conversion | +7,494 | $6.34 | $48K | 76,764 |
| 2017-03-03 | Labrucherie Gil M SVP & Chief Financial Officer | Sale | −7,494 | $15.21 | $114K | 69,270 |
| 2017-03-03 | Labrucherie Gil M SVP & Chief Financial Officer | Exercise or conversion | +25,000 | $9.24 | $231K | 94,270 |
| 2017-03-03 | Labrucherie Gil M SVP & Chief Financial Officer | Sale | −25,000 | $15.21 | $380K | 69,270 |
| 2017-03-03 | Labrucherie Gil M SVP & Chief Financial Officer | Exercise or conversion · Stock Option | −7,494 | 0 |
Page 44 of 55 · 1,088 trades